Section 71 & 15 – ACCEPTED AND ACKNOWLEDGED
on 29 Dec 2023
Last Applicant/ Owned by
Lonzastrasse
Visp
CH
CH-3930
Serial Number
79217900 filed on 20th Jul 2017
Registration Number
5420763 registered on 13th Mar 2018
Correspondent Address
Lawrence J. Crain
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
CHOK1SV GS-KO
Biological substances for scientific research and pharmaceutical research, namely, genetically modified cells and vectors for production of human, animal, and synthetic proteins Biological substances for medical and veterinary therapeutic purposes, namely, genetically modified cells and genetically modified vectors for production of human, animal, and synthetic proteins
Classification Information
Class [005]
Pharmaceutical Products
Biological substances for medical and veterinary therapeutic purposes, namely, genetically modified cells and genetically modified vectors for production of human, animal, and synthetic proteins
Class [001]
Chemical Products
Biological substances for scientific research and pharmaceutical research, namely, genetically modified cells and vectors for production of human, animal, and synthetic proteins
Mark Details
Serial Number
No 79217900
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 6665.136349
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 30th Dec 2023 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
| 29th Dec 2023 | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. |
| 22nd Dec 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 01st May 2023 | TEAS SECTION 71 & 15 RECEIVED |
| 13th Mar 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 14th Feb 2019 | NEW REPRESENTATIVE AT IB RECEIVED |
| 20th Jul 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 19th Jun 2018 | FINAL DISPOSITION PROCESSED |
| 19th Jun 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
| 13th Jun 2018 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |